Second engine igniting off the first: an unplanned-for adjacent revenue stream has started paying, and management is now
The model's full reasoning — Q2 2022 call → NOWe need answer YES/NO. Need analyze transcript. Question asks: Does management describe that a SECOND, DISTINCT WAY OF MAKING MONEY has recently emerged FROM company's existing operations, assets, customers, capabilities - additional revenue avenue that grew out of what company already does rather than separate diversification - AND that this second avenue is ALREADY GENERATING REAL PAYING BUSINESS today while management now deliberately putting effort/resources behind growing it? Need identify in transcript. Management discusses various things. Need find one coherent phenomenon with both halves. Possible candidates: - Oxyfuel offer: "our oxyfuel offer that we have. And recently, obviously, given where energy prices are across the world, but in EMEA in particular, we've had a lot of traction with customers in the course of the first half of this year, helping them improve their processes by injecting oxygen and substituting in part air, but also reducing their natural gas consumption as a consequence. 10 wins already in the first half. We've got at least 15 to 20 other proposals that we're working on." This is an application of existing oxygen product to help customers reduce natural gas. Is this a second distinct way of making money? It's selling oxygen (existing product) to customers for a new application? It's more like product application growth, not necessarily a second avenue. It leverages existing capabilities (oxyfuel technology) and is generating wins, and they are pursuing proposals. But is it distinct from core? It's still selling industrial gases (oxygen) but for energy efficiency. Could be considered an additional revenue avenue from existing capabilities. But question asks "second, distinct way of making money has recently emerged from company's existing operations, assets, customers, or capabilities" - oxyfuel is an application of existing product, not a separate revenue stream? It is a way to sell more oxygen, not a new line of business. It is cross-selling/application development. Likely NO. - Hydrogen/clean hydrogen projects: They have projects, but not necessarily "second avenue" from existing operations? It's a growth area, but not yet paying? They mention projects, but not current revenue? They have backlog? Not clear. - Engineering business: They have engineering division, but that's existing segment. Not new.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| CMLS | Cumulus Media Inc. | Q3 2022 | 2022-10-28 | D |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
LRN · Q1 2019 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows career readiness as a distinct second revenue avenue that emerged directly from the existing MPS business: students already enrolled in Managed Public Schools are being moved into career readiness programs (over 5,000 students), and the initiative is built on the same platform, curriculum, and student base. Management explicitly describes it as a “career readiness line of business” and “robust career readiness business” that is already generating paying enrollments today while they are deliberately investing resources—dedicated executives, reallocation of funds, and plans to drive a major portion of next year’s enrollment growth.
M · Q4 2022 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows that Macy’s Marketplace is explicitly described as a distinct new revenue avenue that emerged directly from their existing e-commerce operations and customer base (macys.com, cross-shoppers, and omnichannel platform). Jeff Gennette states it “captures incremental sales opportunity,” “drives a larger average order value,” “allows us to quickly move into new and adjacent categories without inventory risk,” and “attracts a new younger customer,” while management is actively scaling it by adding 2,000 brands in 2023 and launching Bloomingdale’s marketplace in the back half.
GDRX · Q2 2022 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows that Pharma Manufacturer Solutions is the second distinct revenue avenue that emerged from GoodRx’s existing operations. Trevor explicitly states: “Our distinct ability to reach both consumers and providers continues to be recognized by manufacturers as evidenced by the strong growth.” This capability originated from the core prescription-transactions platform and user base 3 years earlier (when other offerings were only ~5% of revenue). In Q2 2022 it generated $26.6 million (102% YoY growth) and is already producing real paying business.